Welcome to our dedicated page for Corsair Gaming SEC filings (Ticker: CRSR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Corsair Gaming’s strength in high-performance PC gear makes its SEC disclosures a treasure trove of data on product launches, component costs, and e-sports sponsorships. Yet finding when inventory builds pressure margins or when executives exercise options can mean scrolling through hundreds of pages.
Our platform solves that. Stock Titan delivers AI-powered summaries that explain Corsair Gaming SEC filings simply, turning dense 10-Ks into plain-language insights and flagging every Corsair Gaming insider trading Form 4 transaction the moment it hits EDGAR. Whether you need the latest Corsair Gaming quarterly earnings report 10-Q filing or an 8-K on a new streaming-gear acquisition, you’ll see it in real time alongside concise context.
Here’s what you can explore:
- Annual report 10-K simplified – segment revenue, supply-chain risks, R&D for LED cooling, all condensed by AI.
- Form 4 dashboards – Corsair Gaming Form 4 insider transactions real-time with alerts on executive stock movements.
- 8-K material events explained – understand product recalls or leadership changes within minutes.
- Proxy statement executive compensation – see how esports sponsorship bonuses shape pay packages.
- Consistent updates – every filing type, from S-8 to earnings call slides, lands here first.
Analysts monitor gross-margin swings; traders watch Corsair Gaming executive stock transactions Form 4; long-term holders read our Corsair Gaming earnings report filing analysis to track quarterly unit sales. Whatever your angle, our AI surfaces the metrics that matter so you can act before the market digests the fine print.
Corsair Gaming, Inc. (CRSR) – Form 4 insider filing
Chief Financial Officer Michael G. Potter reported a single transaction dated 07/02/2025. The filing shows 1,084 common shares were withheld (Code F) at a price of $9.72 per share to cover income-tax obligations arising from the vesting of previously granted restricted stock units (RSUs). Because the shares were not sold on the open market, the transaction does not represent a discretionary sale.
Following the tax-related share withholding, Mr. Potter’s direct beneficial ownership stands at 123,939 common shares. No derivative securities were acquired or disposed of, and no additional transactions were reported.
Form 4 Code F events are typically viewed as administrative and neutral from a market-impact perspective, as they do not signal a change in the insider’s investment thesis or confidence in the company.
Medicus Pharma Ltd. (Nasdaq: MDCX, MDCXW) has filed Offering Circular Supplement No. 9 under Rule 253(g)(2) to update its April 10, 2025 qualified Regulation A Offering Circular. The supplement registers 1,490,000 common shares that may be issued upon exercise of the company’s publicly-traded warrants, which carry a $4.64 exercise price and expire on 15 November 2029. For reference, the common shares and warrants last traded on 2 July 2025 at $3.22 and $1.00, respectively.
The document primarily incorporates by reference Amendment No. 1 to the company’s 8-K-styled Current Report filed 3 July 2025. The amendment furnishes the complete Share Exchange Agreement dated 29 June 2025 among Medicus, Antev Limited and Antev security-holders. The proposed transaction, if consummated, would add Teverelix—a late-stage prostate-cancer therapeutic candidate—to Medicus’s pipeline. No financial terms or closing conditions beyond those in the agreement are disclosed here.
The company retains “emerging growth company” status and reminds investors of the high-risk nature of the investment and potential dilution from warrant exercises. Other than providing the redacted agreement (Exhibit 2.1) and related XBRL cover page (Exhibit 104), the filing introduces no new financial statements, earnings metrics or guidance.
Investors should review the complete Offering Circular and Exhibit 2.1 for detailed terms, as the supplement is intended to be read together with earlier disclosures.
Golden Matrix Group, Inc. (GMGI) Form 4 filing discloses that Chief Executive Officer, Director, and 10% owner Anthony Brian Goodman sold 50,000 shares of common stock on 30 June 2025 at prices ranging from $1.71-$1.80 (footnote indicates a volume-weighted average price of ≈$1.75). The transaction was reported on 2 July 2025.
Following the disposition, Goodman still controls a substantial stake: 8,854,079 shares held directly and 7,470,483 shares held indirectly through his wholly-owned entity, Luxor Capital LLC, for a combined beneficial ownership of roughly 16.32 million shares. The sale represents ≈0.3 % of his total position, suggesting portfolio management rather than a major reduction in commitment.
No derivative securities activity was reported, and the filing does not reference any Rule 10b5-1 trading plan. Luxor Capital LLC is listed as a joint filer because of its indirect ownership.
- Key take-away: A modest insider sale by the CEO; insider retains a dominant ownership position.
FAQ
What is the current stock price of Corsair Gaming (CRSR)?
What is the market cap of Corsair Gaming (CRSR)?
What is Corsair Gaming, Inc.'s primary business focus?
How does Corsair generate its revenue?
What distinguishes Corsair's products from its competitors?
Which markets does Corsair serve?
How does Corsair maintain its reputation in the tech industry?
What are the key segments of Corsair's business?
How does Corsair support the growing esports and content creation communities?
What makes Corsair's technical expertise evident?
